Researchers have found that dendritic cells (DCs) and tumor-secreted exosomes enable antigen presentation and T cell stimulation by expressing numerous major histocompatibility complex class I molecules (MHC-I) and tumor markers, and trigger CD8+ T cell-dependent antitumor responses in vitro and in vivo (19). This evidence concerns the gene CD8A and neoplasm.